TRAF6 promoted the tumorigenicity of esophageal squamous cell carcinoma

Tumor Biology

Volumn 34, Issue 5, 2013, Pages 3201-3207

  Yao, Feng ^a   Han, Qingqi ^b   Zhong, Chenxi ^a   Zhao, Heng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell growth and apoptosis; ESCC; TRAF6; Tumorigenicity

Indexed keywords

EID: 84885423938     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0890-0     Document Type: Article

References (12)

1. Toh Y, Oki E, Ohgaki K, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol. 2010;15:135-44.
2. Zhou ZQ, Cao WH, Xie JJ, et al. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer. 2009;9:291-7.
3. Yoshinaga K, Yamashita K, Mimori K, Tanaka F, Inoue H, Mori M. Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells. Ann Surg Oncol. 2008;15(1):96-103.
4. Inoue J, Gohda J, Akiyama T. Characteristics and biological functions of TRAF6. Adv Exp Med Biol. 2007;597:72-9.
5. Daniel TS, William WL, Sophie D. TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer. J Clin Invest. 2011;121(10):4095-105.
6. Hirata Y, Ohmae T, Shibata W, et al. MyD88 and TNF receptor-associated factor 6 are critical signal transducers in Helicobacter pylori-infected human epithelial cells. J Immunol. 2006;176(6):3796-803.
7. Bradley JR, Pober JS. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene. 2001;20(44):6482-91.
8. Yang WL, Wang J, Chan CH, et al. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science. 2009;325:1134-8.
9. Zhang W, Chen H, Liu DL, et al. Emodin sensitizes the gemcitabine-resistant cell line Bxpc-3/Gem to gemcitabine via downregulation of NF-κB and its regulated targets. Int J Oncol. 2013;42(4):1189-96.
10. Bastian L, Hof J, Pfau M, et al. Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB. Clin Cancer Res. 2013;19(6):1445-57.
11. Peinado C, Kang X, Hardamon C, et al. (2013) The NF-κB pathway down-regulates expression of the NKG2D ligand H60a in vitro: implications for use of NF-κB inhibitors in cancer therapy. Immunology doi: 10.1111/imm.12080.
12. Wang F, He W, Fanghui P, et al. (2013) NF-kappa BP65 promotes invasion and metastasis of esophageal squamous cell cancer by regulating matrix metalloproteinase-9 and epithelial-to-mesenchymal transition. Cell Biol Int doi: 10.1002/cbin.10089.